menu

How to Integrate AKI Risk Assessments into Clinical Workflows

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

How to Integrate AKI Risk Assessments into Clinical Workflows

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    By using biomarkers of acute kidney injury (AKI) to optimize our risk assessments, they may be able to pinpoint what's causing the injury, what's the best therapeutic approach to attenuating or mitigating that injury, and how we can improve outcomes for patients. But there are several obstacles that keep us from incorporating these optimized tests into our workflows. That’s why Dr. Charles Turck speaks with Drs. Javier Neyra and Jonathan Himmelfarb about the important role biomarkers play in stratifying a patient’s AKI risk and how we can integrate these risk assessments into clinical workflows. Dr. Neyra is the Co-Director of Critical Care Nephrology at the University of Alabama at Birmingham, and Dr. Himmelfarb is the Co-Director of the Center for Dialysis Innovation at the University of Washington.  

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    By using biomarkers of acute kidney injury (AKI) to optimize our risk assessments, they may be able to pinpoint what's causing the injury, what's the best therapeutic approach to attenuating or mitigating that injury, and how we can improve outcomes for patients. But there are several obstacles that keep us from incorporating these optimized tests into our workflows. That’s why Dr. Charles Turck speaks with Drs. Javier Neyra and Jonathan Himmelfarb about the important role biomarkers play in stratifying a patient’s AKI risk and how we can integrate these risk assessments into clinical workflows. Dr. Neyra is the Co-Director of Critical Care Nephrology at the University of Alabama at Birmingham, and Dr. Himmelfarb is the Co-Director of the Center for Dialysis Innovation at the University of Washington.  

Facebook Comments

Schedule25 May 2024